Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L LINDSAY

Showing results (321-330 of 346) with videos related to

Pageof 35
Sort By:
Hepatology (Baltimore, Md.)|October 14, 2009
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trialZachary D Goodman, Anne M Stoddard, Herbert L Bonkovsky, et al.
Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.
Gastroenterology|December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis CAnna S Lok, James E Everhart, Elizabeth C Wright, et al.
Hepatology (Baltimore, Md.)|March 18, 2009
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trialAnna S Lok, James E Everhart, Raymond T Chung, et al.
The New England Journal of Medicine|December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferonAdrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trialAnna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok, Marc G Ghany, Zachary D Goodman, et al.
Pageof 35

Showing results (321-330 of 346) with videos related to

Sort By:
Pageof 35
Hepatology (Baltimore, Md.)|October 14, 2009
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trialZachary D Goodman, Anne M Stoddard, Herbert L Bonkovsky, et al.
Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.
Gastroenterology|December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis CAnna S Lok, James E Everhart, Elizabeth C Wright, et al.
Hepatology (Baltimore, Md.)|March 18, 2009
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trialAnna S Lok, James E Everhart, Raymond T Chung, et al.
The New England Journal of Medicine|December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferonAdrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trialAnna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok, Marc G Ghany, Zachary D Goodman, et al.
Pageof 35